Allergan, Inc. (NYSE:AGN)

100 dollar bills

What to Expect From Major Companies Reporting Earnings on Wednesday

24/7 Wall St. has put together a preview of some of the most anticipated quarterly results due on Wednesday. The broad markets hit new highs on Tuesday, giving more credence ...
Read Full Story »
blue cart

5 Cheap Stocks to Buy From Merrill Lynch’s Focus List for a Very Expensive Market

In the euphoria of the long-awaited push through the 20,000 level on the Dow Jones Industrial Average, there is a potential train-wreck waiting to happen, and investors need to be ...
Read Full Story »
Unhealthy Person

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

When traders look at a stock at its highs and imagine what would be had they gotten in at the lows, the thought that invariably gets triggered is “At the ...
Read Full Story »
percentage button

Hedge Funds Dumped Allergan, Bought Procter & Gamble in Q3

Consumer staples represented the largest aggregate purchases among the top 50 hedge funds during the third quarter of 2016. The hedgies bought $12.2 billion worth of stock in consumer staples ...
Read Full Story »
investing

Hedge Funds Bought Apple, P&G in Q3; Dumped Allergan, Charter

Building on a turn toward more equity investments in the second quarter of this year, the top 50 hedge funds boosted their equity positions by 2.9% in the third quarter. ...
Read Full Story »
upside

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

If any sector has had a tough go of it the past year, it has been health care, and especially biotechnology. Continued harsh rhetoric from politicians, especially the Democrats, over ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

Stocks were up very slightly on Monday morning, but not enough to offset Friday's sell-off after the Clinton email situation was brought back front and center. The earnings floodgates are ...
Read Full Story »
Unhealthy Person

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes PLC (NASDAQ: ALKS) just announced positive Phase 3 results for its novel antidepressant ALKS 5461, and it’s serving as a rising tide — a storm surge even — for many biotech ...
Read Full Story »
GettyImages_183162370

Tobira Therapeutics Skyrockets on Allergan Acquisition

Tobira Therapeutics Inc. (NASDAQ: TBRA) shares skyrocketed on Tuesday after Allergan PLC (NYSE: AGN) announced that it will acquire the company. Both boards of directors have unanimously approved the transaction ...
Read Full Story »
M&A

Vitae Shares Jump Over 150% on Allergan Acquisition

Allergan PLC (NYSE: AGN) announced early on Wednesday that it would be acquiring Vitae Pharmaceuticals Inc. (NASDAQ: VTAE). The goal of this transaction is to bolster Allergan’s dermatology product pipeline, and ...
Read Full Story »
Prescription drugs

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer Inc. (NYSE: PFE) has finally reeled in cancer-drug maker Medivation Inc. (NASDAQ: MDVN) for a whopping $81.50 a ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson, Hormel and More

Stocks may be at all-time highs, but a lack of catalysts has shares soft on Friday. Low interest rates and a lack of other asset classes offering a return keep ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »
white pills

Why Allergan Earnings Aren’t Telling the Whole Story

The big news for Allergan PLC (NYSE: AGN) came early in the second quarter, when Pfizer Inc. (NYSE: PFE) terminated its proposed $160 billion acquisition of the Ireland-based maker of Botox. ...
Read Full Story »
white pills

What Expect From Teva Earnings

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is scheduled to release its second-quarter financial results before the markets open on Thursday. This company has so far been unable to escape its rough ...
Read Full Story »